Every article, report, and earnings note where DXCM appears.
DexCom is executing well with double-digit revenue growth, expanding margins, and broader adoption of G7 15 Day and Stelo. The stock remains a Hold because the business is strong, but valuation already reflects much of the upside.
DexCom, Inc. (DXCM) rises after Elliott Investment Management disclosed a stake and reached a cooperation agreement with the company. The move came alongside governance changes, strong Q1 revenue growth, and raised margin guidance, giving investors a clearer case for tighter execution and continued momentum.
Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.
Generate DXCM ReportCancel anytime